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Abstract
In a study looking for risk factors of atherosclerosis in
families with combined hyperlipidemia and hyperten-
sion, clinical and biochemical data of 1,149 persons were
analyzed to develop two hypothetical multivariate scores
concerning the degree to which a patient is affected by
the metabolic syndrome. The scores are based on a
structural model for low-density cholesterol (LDL) and
high-density cholesterol (HDL), triglycerides, uric acid,
creatinine, glucose, insulin, systolic blood pressure and
waist-to-hip ratio. Age, gender and body mass index
were used for adjusting all variables. In segregation anal-
yses of 42 pedigrees without using genotype informa-
tion, estimations of the heritabilities and environmental-
ly caused variance and covariance components were
computed for the individual score values of the two
latent factors. The first score shows a heritability of 42%;
the environment component disappeared. The score
mainly reflects the HDL, LDL and triglyceride levels. The
second score shows a heritability of 16% with an envi-
ronment component of 7%. It includes mainly insulin,
uric acid and creatinine. In the search for genetic causes,
both scores could be a basis for further phenotypic clas-
sification of the metabolic syndrome.
Copyright © 2001 S. Karger AG, Basel
Introduction
The results of previous search for genetic causes of the
metabolic syndrome suggest polygenetic events. A con-
vincing method to discriminate phenotypes for familial
combined hyperlipidemia or more generally for the meta-
bolic syndrome, which could qualify for systematic link-
age analyses with some candidate genes or marker loci,
has not been discovered yet. Existing classifications of lip-
id disorders [1] are predominantly based on lipid and
apolipoprotein concentrations and partially include clini-
cal findings. On linkage analysis, no single ultracentrifu-
gation variable for the diagnosis of familial combined
hyperlipidemia could reliably discriminate affected fami-
ly members from nonaffected members [2]. There are var-
ious strategies to include several of such quantitative vari-
ables into the definition of phenotypes or into linkage
analyses with the aim to increase the chances of finding
linkages with genetic markers. Examples include cluster
analyses of diagnostic parameters [3], explorative factor
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Table 1. Parameters used in the analyses, means and standard devia-
tions (SD) in the sample
Variables No. of
endogenous
manifest variable
Mean SD
1.72 1.49
log triglycerides 1 0.335 0.609
HDL cholesterol, mmol/l 2 1.35 0.39
LDL cholesterol, mmol/l 3 3.41 1.30
Uric acid, Ìmol/l 4 318 87
Creatinine, Ìmol/l 5 88 18
Glucose, mmol/l 4.33 1.73
log glucose 6 1.38 0.45
Insulin, nmol/l 0.080 0.068
log insulin 7 –2.73 0.60
Systolic blood pressure 8 132.2 19.8
Waist-to-hip ratio 9 0.867 0.104
Age 41.5 17.0
Sex 601 males
548 females
Body mass index, kg/m2 10 25.2 4.7
analyses [4, 5], the development of path models for hypo-
thetical relationships between the variables [6, 7], and the
estimation of genetic and environmental variance compo-
nents [8–10]. Our approach combines methods of struc-
tural analysis with the estimation of genetic variance com-
ponents. In a first step, the observed correlation matrix of
the variables in the sample is reproduced by a linear struc-
tural model with two latent variables. In a second step,
one of these latent variables is identified as a hypothetical
genetic component by bivariate estimation of genetic and
environmental variance components. The factor values of
these latent variables can also be individually estimated
for further persons and they indicate to which degree a
person is affected with various lipid metabolism disor-
ders. Thus, our approach describes a reduction in the
dimension of the diagnostic variables to two latent vari-
ables and a subsequent bivariate estimation of the vari-
ance and covariance components of these latent variables.
Alternatively to our approach, a continuous multivariate
strategy could use the first principal component of the
genetic covariance matrix of all original diagnostic vari-
ables to define the phenotype. However, this principal
component could only be interpreted medically with diffi-
culty and it would be less likely to be accepted as a pheno-
typic trait. In comparison, our approach has the advan-
tage of the plastic model of relationships between the orig-
inal variables and the ability of interpreting the latent
variables as clinical score for the affect referring to the
metabolic syndrome. Besides, considerable less parame-
ters of the model have to be estimated in comparison to
the continuous multivariate approach. In addition, the
request for the first principal component to deliver maxi-
mal variance reproduction with the aim to make it
unique, appears artificial in a physiological context.
A further advantage of the structural model is the inte-
gration of reliable knowledge about causal associations
between biochemical parameters and further clinical and
paraclinical parameters. As an example, the work of Chan
et al. [7] can be given. In a causal path model, associations
are described between glucose, triglycerides, insulin, uri-
nary albumin, blood pressure, age, body mass index,
waist-to-hip ratio and family history for patients with dia-
betes mellitus.
Methods
Step One: Structural Model for the Correlations and Estimation
of the Scores
Data Collection. The sample for the development of the structural
model was taken from the data bank of our atherosclerosis study
group [11, 12]. Patients who have been cared for on an outpatient
basis at our Lipid Clinic and at the Department of Internal Medicine
have been included in the study on a voluntary basis (written con-
sent). A known diabetes mellitus, a malignant or any other life-threat-
ening disease were exclusion criteria. A systematic history was taken
and blood sampling was only done in periods without relevant acute
diseases or without severe illnesses or operations in the last months.
Family members of these index patients have been invited to take
part in the same program. The main target of the study was to identi-
fy families with hypertriglyceridemia or combined hyperlipidemia,
and thus no medication has been discontinued. Blood samples were
taken after an overnight fast. All 1,149 persons with a complete set of
biochemical parameters were selected from the data bank. The sam-
ple consisted of 42 families with 308 members and 841 single per-
sons: 601 males aged 42.4 B 16.9 (range 5–86) years and 548 females
aged 40.9 B 17.1 (range 4–86) years. In an epidemiological perspec-
tive, the analysis is based on a cross-sectional survey of a mixed pop-
ulation consisting of affected index persons and optionally of their
relatives and partners. We assume the same correlation structure
between the variables for all members of this mixed population. This
implies that the hypothetical genetic influences on a single individual
only change the expected values of variables but not the association
structures between variables. This assumption is possibly too re-
strictive in a medical sense, but it is unavoidable even in the contin-
uous approach described above.
Laboratory Assays. Table 1 summarizes the variables used in the
analysis. For all laboratory parameters, standard biochemical meth-
ods were used as published before [13], total serum cholesterol:
CHOD-PAP (Boehringer Mannheim); serum triglycerides: GPO-
PAP (Boehringer Mannheim); high-density lipoprotein cholesterol
(HDCL-C): precipitation of apolipoprotein-B-containing lipopro-
teins with polyphosphotungstate and magnesium ions; and cholester-
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ol determination (Boehringer Mannheim), low-density lipoprotein
cholesterol (LDL-C): LDL precipitation with dextran sulfate,
CHOD-PAP and cholesterol determination (ImmunoGmbH/Boeh-
ringer Mannheim); uric acid: uricase-PAP (Boehringer Mannheim);
creatinine: Jaffé (Boehringer Mannheim); serum glucose: GOD-PAP;
insulin after an overnight fast: insulin RIA Coat-A-Count (DPC). A
strict quality control was obligatory for all laboratory tests. To
improve the normal distribution, the natural logarithms were used
for triclyceride, insulin and glucose serum concentrations.
Structural Modeling. The aim of the structural model is to explain
the observed correlation structure between the diagnostic variables
adjusted for age, gender and body mass index by superposing partial
correlations of the variables with common correlations and correla-
tions with two hypothetical latent factors. All manifest variables were
centered by the mean of the sample.
With the endogenous manifest variables
Ë = (Y1, ..., Y10))
(table 1) and the exogenous variables
Í = (Age, Sex, F(1), F(2), E1, ..., E10))
the structural model results in the presentation of Bentler and Weeks
[14]
Ë = ßË + ÁÍ.
The variables age and sex serve as adjustment of the endogenous
variables. F(1) and F(2) are two latent variables, and E1, ..., E10 are the
residual errors for the variables Y1, ..., Y10. The parameters ß and Á of
the model are estimated by the maximum likelihood method, and the
final model was found by several steps of model selection with the
aim of optimal model fit.
All laboratory parameters of our structural model and the two
variables systolic blood pressure and waist-to-hip ratio were adjusted
for age, sex and body mass index. Furthermore, the body mass index
itself was adjusted for age and sex. In this way, age, sex and the hypo-
thetical factors F(1) and F(2) are the only exogenous variables of the
model, i.e. only these variables vary completely independently. A
certain part R2 of the variance of all other variables results from the
associations which are described in the model.
The greater R2 the stronger the observed variability of the param-
eter is predetermined by the remaining variables of the model. The
remaining part 100% – R2 expresses the part of the independent vari-
ability of a variable and is a measure of the information it contributes
for the further evaluation of a patient. The observed correlations
between the variables consist of associations which can be explained
biochemically or physiologically (shown in the model by duplicate
arrows) and of common correlations which arise by the latent factors.
The development of our structural model is based on the results of an
explorative maximum likelihood factor analysis for the variables
used. Computations are carried out by the SAS CALIS procedure
[15] using maximum likelihood methods.
In our model, we interpret the two postulated latent variables as
unobservable factors which reflect initially unknown causes. In the
second step, we try to identify these causes as genetic causes and/or
environmental causes. These latent factors contribute to the ob-
served variances and covariances of the variables. They have a bivar-
iate standard normal distribution in the population. However, their
least square estimations in the sample have a slightly smaller stan-
dard deviation and are not unbiased [16]. Of course, this model is
based on theoretically justified associations between the variables
and is only valid under the conditions of both statistical and theoreti-
cal evidence. Since different models of this kind can be set up with
the same data, the inference has an exploratory character only. The
statistical evidence of our model and of the estimated parameters
results from several characteristics (p value for the whole model, p
values for single coefficients and covariances, sufficiently small and
normally distributed residuals, rates of explained variances of the
variables, goodness of fit indices).
Step two: Estimations of Variance Components – Research
Design and Methods
The same sample as in step one was used. The sample is divided
into pedigrees of 42 families with 308 members and 841 single per-
sons. With segregation analyses, without using information about
genotypes, the covariance matrices of the estimated scores from step
one were separated for all members of each family into the genetic,
environment and residual variance and covariance components.
Here, we assume that variability in the two scores F(1) and F(2) is due
to the summed effects of additive polygenes, environment factors
shared by members of the same household, or of the same sibship, or
of the same couple, and a residual effect specific to each individual
which may reflect measurement errors in the original variables and
errors in the structural model. Under these assumptions, the 2n ! 2n
covariance matrix for a family with n members is
ø = Û2aF(1) ÛaF(1)F(2)
ÛaF(1)F(2) Û2aF(2)
 b 2∑(n ! n) + Û2uF(1) ÛuF(1)F(2)
ÛuF(1)F(2) Û2uF(2)
 b U(n ! n)
+ Û2eF(1) ÛeF(1)F(2)
ÛeF(1)F(2) Û2eF(2)
 b I(n ! n),
where Û2aF(1) is the additive genetic variance of the score F(1), Û2aF(2) is
the additive genetic variance of the score F(2), ÛaF(1)F(2) is the additive
genetic covariance between F(1) and F(2), Û2uF(1), Û2uF(2), ÛuF(1)F(2) are the
corresponding variance and covariance components for the environ-
mental factor, and Û2eF(1), Û2eF(2), ÛeF(1)F(2) are the corresponding residual
variance and covariance components. b is the Kronecker product of
matrices, ∑ is the known n ! n matrix of the kinship coefficients
representing half the theoretical correlations between pedigree mem-
bers, and U is the n ! n matrix of indicators for a common house-
hold with 0 = none and 1 = yes.
Four further parameters were included in the model: the expected
values of the variables F(1) and F(2) of all members of the 42 families
and the corresponding expected values of all single individuals with-
out family members in the sample. Thus, a possible bias from the
family part of the sample compared with the part of single individu-
als is taken into consideration. Alternatively, an ascertainment cor-
rection for all index patients was used basing on conditional likeli-
hood. This variant was dropped because the results did not prove
different. The log likelihood for a family based on multivariate nor-
mal distribution of the outcome variable y = (F1
(1), ..., Fn
(1), F1
(2), ...,
Fn
(2))) in all n members of a family is with the exception of noninfor-
mative terms
ln L ∝ – 1
2
ln det ø – 
1
2
(y – AÌ)) ø–1 (y – AÌ).
The 2n ! 4 matrix A denotes the indicators for the components of
the mean Ì = (ÌF(1),family, ÌF(1),single ÌF(2),family, ÌF(2),single)) in the two parts
of the sample, the part with all members of families and the part of
single persons. Of course, the covariance matrix ø collapses to a
2 ! 2 matrix for a single person without data from his/her family,
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Fig. 1. Structural model with path coefficients for the variables log insulin [ln(INS)], log glucose [ln(GLUC)], creati-
nine (CREA), uric acid (UA), body mass index (BMI), log triglycerides [ln(TG)], low-density cholesterol (LDL),
high-density cholesterol (HDL), systolic blood pressure (RRS), waist-hip ratio (WHR), age and sex.
and such a person does not contribute information for the variance
and covariance components but for the means only.
The maximum likelihood estimations of the model parameters
are based on scoring iteration [9] and were carried out with our own
SAS-IML [17] programs.
The standard errors of the estimated parameters result from
asymptotic estimations from the inverse of the information matrix in
the whole model.
Results
Figure 1 shows the structural model. The p value of the
¯2 statistic for the model is 0.68 and, together with other
characteristics, shows a sufficient fit of the model to the
data (goodness of fit index GFI = 0.998; maximum abso-
lute deviation of the correlation predicted by the model
from the observed correlations 0.037; good correspon-
dence of the residuals to normal distribution). Only few
two-sided and no one-sided associations were taken into
the model. Nevertheless, these few associations together
with both the latent factors F(1) and F(2) are adequate to
explain the remarkably high parts of variance and covar-
iance of the variables. In this model, the variable LDL is
especially strongly predetermined (R2 = 65%). HDL (R2 =
52%), triglycerides (R2 = 54%), waist-to-hip ratio (R2 =
61%) and uric acid (R2 = 61%) show an explained high
variance as well. The path coefficients of the latent factors
to the original variables allow an interpretation of the fac-
tors. Thus, high factor values of F(1) show pathologically
increased LDL (path coefficient 0.66), triglycerides
(0.41), insulin (0.13), waist-to-hip ratio (0.13) and de-
creased HDL cholesterol (–0.57). The known negative
correlation between LDL and HDL is reproduced by the
latent variable F(1) but not by the bivariate residual corre-
lation (path coefficient 0.31). Factor F(2) reflects mainly
increased uric acid (path coefficient 0.40), insulin (0.40)
and triglycerides (0.32). The body mass index can be
explained by a 22% share of the variance of age and sex.
Triglycerides, mmol/l
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The remaining 78% of the variance result from exogenous
nonobserved sources. An influence of the two latent fac-
tors on the body mass index is excluded in this model.
With the present data, other potential associations could
not be shown by the model.
On the basis of this structural model, both score values
can be estimated for each person by a simple computa-
Table 2. Regression coefficients for the estimation of the scores bas-
ing on the standardized original variables, and means and standard
deviations of the estimated scores F(1) and F(2)
Variables Score
coefficient
for F(1)
Score
coefficient
for F(2)
log triglycerides 0.22 0.23
HDL cholesterol, mmol/l –0.58 0.12
LDL cholesterol, mmol/l 0.78 –0.04
Uric acid, Ìmol/l –0.05 0.52
Creatinine, Ìmol/l –0.04 0.27
Glucose, mmol/l
log glucose –0.13 –0.07
Insulin, nmol/l
log insulin 0.09 0.31
Systolic blood pressure –0.02 0.16
Waist-to-hip ratio 0.02 0.13
Age –0.23 –0.18
Sex 0.26 0.50
Body mass index, kg/m2 –0.33 –0.39
Mean 0.00 0.00
Standard deviation 0.97 0.74
Table 3. Bivariate analysis of the scores F(1) and F(2)
Model Model parametersa
Û2aF1 Û2aF2 ÛaF1F2 Û2uF1 Û2uF2 ÛuF1F2 Û2eF1 Û2eF2 ÛeF1F2 ÌF1, family ÌF1, single ÌF2, family ÌF2, single
Akaikeb
0.454
(0.028)
0.122
(0.008)
–0.080
(0.008)
0.000
(0.006)
0.050
(0.002)
0.025
(0.002)
0.543
(0.013)
0.350
(0.004)
0.140
(0.004)
0.027
(0.006)
0.264
(0.003)
–0.006
(0.001)
–0.100
(0.001)
–717.27
Without covariances 0.474
(0.029)
0.133
(0.009)
– 0.000
(0.006)
0.046
(0.002)
– 0.532
(0.013)
0.344
(0.004)
– 0.025
(0.006)
0.263
(0.003)
–0.006
(0.001)
–0.100
(0.001)
–737.19
Without means 0.467
(0.029)
0.200
(0.009)
–0.048
(0.008)
0.000
(0.006)
0.046
(0.002)
0.018
(0.002)
0.534
(0.013)
0.299
(0.004)
0.117
(0.004)
– – – – –736.55
Without covariances
and means
0.478
(0.029)
0.206
(0.009)
– 0.000
(0.006)
0.044
(0.002)
– 0.529
(0.013)
0.294
(0.004)
– – – – – –746.96
a Maximum likelihood estimations. Figures in parentheses are standard errors.
b Akaike criterion = log likelihood minus number of estimated parameters.
tional instruction. As expected, the scores of all persons in
our sample built a scatterplot in regular form around the
origin corresponding to a bivariate normal distribution. A
clustering of the scores into distinct types is not ob-
served.
Table 2 shows the score regression coefficients and
means and standard deviations of the estimated scores
F(1) and F(2). Table 3 contains the results of the estimation
of the variance and covariance components for some dif-
ferent models. The Akaike information criterion pre-
ferred the full model. The model without covariances
does not show a significant deterioration compared to the
full model (likelihood ratio test p = 0.060) and should be
preferred for statistical reasons because of the theoretical
absence of correlation between the two latent variables.
Merely the least square estimation procedure of F(1) and
F(2) generated a correlation between the scores. Both mod-
els show nearly the same estimations of the variance and
covariance components. In the models which include
parameters for the means, the difference of the estimated
means is surprisingly clear between the two parts of the
sample, the part of family members and the part of single
individuals. This difference may reflect a bias in the sam-
pling procedure in favor of family members [18]. As
hoped, one of the latent variables (F(1)) shows a clear
genetic effect measured by the additive genetic variance
component. This is right in all models. Especially in the
full model, the variance component for additive genetic
effects is estimated at 0.454, corresponding to a heritabili-
ty of 42%, and a negligible environmental effect. The oth-
er latent variable (F(2)) shows low effects in both variance
components only (16% heritability and 7% environ-
ment).
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Discussion
The well-known dependence of laboratory parameters
on age, sex and body mass index is quantified in the struc-
tural model by the path coefficients and by and large con-
firms our expectations. Alternatively, the body mass in-
dex could be considered as an endogenous variable. In
this case the variable would be the result and not the cause
of the metabolic syndrome. However, a structural model
which reflects this idea could not be derived from our
data.
The score F(1) seems to be quite suitable as a quantita-
tive phenotypic multivariate trait to search for genetic
linkage with candidate genes or genetic markers. It re-
flects mainly triglycerides and both fractions of cholester-
ol and involves their high heritability (heritability of log
triglycerides 24–31% [8], 27% estimated using our own
data; heritability of HDL 35% and of LDL 29% both esti-
mated using our own data). Surprisingly, the score F(1)
does not point out any environment component. F(2)
seems rather to be determined by both, genetic and envi-
ronmental influences.
In conclusion, two hypothetical latent factors prove to
be effective in the modeling of associations between
adjusted laboratory parameters and findings in a structur-
al model. One of these factors, which combines informa-
tion mainly about cholesterol fractions and triglycerides,
shows a comparatively high estimation value of the heri-
tability and a disappeared environment component.
Thus, it appears suitable as a quantitative phenotypic
trait in linkage analyses for the search of genetic causes of
the metabolic syndrome. The second factor F(2) shows rel-
atively low estimation values for variance components
which are caused both by genetic and environmental
effects. In contrast to estimated principal components,
the estimated scores of this latent variable can be inter-
preted in a context of associations, caused by physiologi-
cal factors.
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